Cargando…

Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation

Natural killer (NK) cells are a promising tool for the use in adoptive immunotherapy, since they efficiently recognize and kill tumor cells. In this context, ex vivo cultivation is an attractive option to increase NK cells in numbers and to improve their antitumor potential prior to clinical applica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granzin, Markus, Wagner, Juliane, Köhl, Ulrike, Cerwenka, Adelheid, Huppert, Volker, Ullrich, Evelyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405078/ https://www.ncbi.nlm.nih.gov/pubmed/28491060 http://dx.doi.org/10.3389/fimmu.2017.00458

Ejemplares similares

Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
por: GRANZIN, MARKUS, et al.
Publicado: (2015)

Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property
por: Delso-Vallejo, María, et al.
Publicado: (2017)

Memory of Infections: An Emerging Role for Natural Killer Cells
por: Rölle, Alexander, et al.
Publicado: (2013)

Hepatitis C Virus and Human Cytomegalovirus—Natural Killer Cell Subsets in Persistent Viral Infections
por: Pollmann, Julia, et al.
Publicado: (2017)

New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)

Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro
por: Tanaka, Yoshitaka, et al.
Publicado: (2019)

Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells
por: Merkt, Wolfgang, et al.
Publicado: (2016)

Radiation effects on antitumor immune responses: current perspectives and challenges
por: Walle, Thomas, et al.
Publicado: (2018)

Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
por: Walle, Thomas, et al.
Publicado: (2022)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Peripheral blood natural killer cell percentages in granulomatosis with polyangiitis correlate with disease inactivity and stage
por: Merkt, Wolfgang, et al.
Publicado: (2015)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
por: Yossef, Rami, et al.
Publicado: (2015)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Editorial: Translating NK cell scientific research to clinical product manufacturing
por: Ullrich, Evelyn, et al.
Publicado: (2023)

Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin
por: Jarahian, Mostafa, et al.
Publicado: (2011)

MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells
por: Breunig, Christian, et al.
Publicado: (2017)

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy
por: Kang, Lin, et al.
Publicado: (2013)

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
por: Lieberman, Nicole A. P., et al.
Publicado: (2018)

Ex Vivo Expansion of Highly Cytotoxic Natural Killer Cells Using Optimal Culture Medium
por: Kim, Seokho
Publicado: (2022)

Isolation and ex vivo cultivation of single myofibers from porcine muscle
por: Stange, Katja, et al.
Publicado: (2020)

Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
por: Weil, Sandra, et al.
Publicado: (2017)

Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids
por: Giannattasio, Ariane, et al.
Publicado: (2015)

Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
por: Denman, Cecele J., et al.
Publicado: (2012)

Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion
por: Allan, David S.J., et al.
Publicado: (2021)

Comparison of culture media for ex vivo cultivation of limbal epithelial progenitor cells
por: Loureiro, Renata Ruoco, et al.
Publicado: (2013)

Deprivation of human natural killer cells and antitumor immune response
por: Ogay, Vyacheslav, et al.
Publicado: (2014)

Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function
por: Mantesso, Simone, et al.
Publicado: (2020)

In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells
por: Niu, Chao, et al.
Publicado: (2015)

Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors
por: Nakazawa, Tsutomu, et al.
Publicado: (2022)

Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses
por: Earl, Patricia L., et al.
Publicado: (2020)

Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2008)

Natural killer cells as a therapeutic tool for infectious diseases – current status and future perspectives
por: Schmidt, Stanislaw, et al.
Publicado: (2018)

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2008)

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2015)

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
por: Lundqvist, Andreas, et al.
Publicado: (2011)

Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy
por: Zhang, Xiaokui, et al.
Publicado: (2015)

Ex vivo expansion of human peripheral blood natural killer cells and cytotoxic T lymphocytes from lung cancer patients
por: Nhung, Hoang Thi My, et al.
Publicado: (2018)

Real-Time Tracking of Ex Vivo-Expanded Natural Killer Cells Toward Human Triple-Negative Breast Cancers
por: Uong, Tung Nguyen Thanh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rn88c5l6lc9af1ov52ji2gi1r0